Neuropsychology is the scientific study of neural correlates for cognition and behavior, with a specific clinical interest in patients presenting with a range of medical, neurological, and psychiatric illnesses. Neuropsychologists are specialized clinicians who receive extended fellowship training (with available board certification) in functional neuroanatomy, neurobiology, psychopharmacology, neurological illness or injury, neuroimaging, psychometric and statistical principles of neurocognitive measures, and clinical psychology. Neuropsychological evaluation refines neuroimaging and neurological examinations by operating from a biopsychosocial framework to determine the extent to which cognition and behavior are affected by brain dysfunction. Neuropsychologists aim to characterize and objectively quantify abilities ranging from simple sensory and motor functions to complex “higher cognitive abilities” that include cognitive processing speed, attention, language, visuoperception, constructional praxis, memory, executive functioning (behavioral, cognitive, and motivational aspects), and emotional/personality functioning.

In this chapter, we begin by explaining the goals and utility of neuropsychology and describing the neuropsychological evaluation. Guidelines are then suggested for brief cognitive screenings that may be useful for neurologists in clinical settings. Finally, the typical patterns of cognitive impairments associated with major neurological disorders are discussed.

Goals of Neuropsychology

When neural damage is present or cognitive changes are observed, a neuropsychological evaluation is appropriate. The prominent neuropsychologist Arthur best described neuropsychology as “a refinement of clinical neurological observation [that] serves the function of enhancing clinical observation [and] is closely allied to clinical neurological evaluation and in fact can be considered to be a special form of it” (p. 68). Neuropsychological assessment aims to extend the neurological examination by: (1) providing important information for differential diagnosis and prognosis; (2) identifying the cognitive, emotional, and behavioral deficits of disease or injury and characterizing their severity; (3) intervention and functional needs such as guiding treatment by using test results to select effective rehabilitation strategies, determining functional capacity and decision-making abilities for level-of-care decisions, driving and work capacity, assessing medication cognitive side effects, and establishing candidacy for surgical procedures; and (4) monitoring cognitive changes and treatment effectiveness across time. Neuropsychological assessment is also frequently used in forensic settings and for neuroscience research, but discussion on these topics is beyond the clinical focus of this chapter ( ).

Before the advent of neuroimaging in the 1970s and 1980s, one of the main goals of neuropsychology was lesion localization. Today, neuropsychology has shifted toward differential diagnosis when lesions may not be evident or in conditions with no clear biomarkers. For example, neuropsychologists assist in the early identification of various dementias, since they are primarily diagnosed based on patterns of clear cognitive declines and behavioral disturbances: Table 44.1 gives a comparison of cortical versus subcortical dementias as an example. Neuropsychological testing is also useful for diagnosing “non-neurological” conditions that can affect cognitive functioning or masquerade as neurocognitive disease, such as dementia of depression or somatoform disorders. Exaggerated and manufactured symptoms can also be clearly identified through the use of stand-alone and embedded measures of symptom and performance validity.

TABLE 44.1
Neuropsychological Characteristics of Cortical Versus Subcortical Dementia Using Alzheimer Disease and Huntington Disease as Examples
Adapted from Salmon, D.P., Filoteo, J.V., 2007. Neuropsychology of cortical versus subcortical dementia syndromes. Semin Neurol 27, 7–21.
Alzheimer Disease (Cortical Dementia) Huntington Disease (Subcortical Dementia)
Learning and Memory
Episodic memory Impaired encoding/consolidation Impaired information retrieval
Poor delayed recall and recognition memory Recognition memory is better than delayed recall
Retrograde amnesia Severe, temporally graded, retrograde amnesia Mild, nongraded, retrograde amnesia
Priming Impaired Preserved
Implicit procedural/motor learning Preserved Impaired
Implicit cognitive skill learning Preserved Impaired
Attention/concentration Relatively preserved Poor auditory and visual attention
Processing speed Relatively intact Very slow
Executive Functioning
Set shifting Better able to shift focus Difficulty with perseveration
Working memory Mild deficits in ability to manipulate information, but preserved phonological loop and visuospatial sketchpad Early notable deficits in phonological loop, visuospatial sketchpad, and ability to manipulate information
Language and Semantic Knowledge
Speech Preserved Dysarthric and slow
Fluency More impaired semantic fluency than phonemic fluency Severe and equal impairment in phonemic and semantic fluency
Naming Impaired; more semantic errors (e.g., calling a lion “an animal”) Relatively preserved; more perceptual errors (e.g., calling a bucket “a cup”)
Structure of semantic knowledge Tend to focus on concrete perceptual information Able to focus on abstract conceptual knowledge

Another goal of neuropsychology is to accurately describe cognitive deficits and their severity. Even when the cause of cognitive dysfunction is clear (e.g., traumatic brain injury) or lesions are evident on imaging, the cognitive and behavioral manifestations of neural damage can be heterogeneous. The interaction among symptom onset, etiology, and patient characteristics results in a wide range of individual variability in cognitive deficits. For instance, the neuropsychological profiles of stroke and tumor patients can be very dissimilar even after matching for lesion location (tumor patients show notably less severe language deficits in the left hemisphere, presumably due to the acute versus chronic etiologies; ). Repeated neuropsychological evaluations are also useful for monitoring the decline of neurodegenerative diseases over time, given the potential for varying degrees of disease progression across patients.

In addition to offering information regarding the diagnosis and clinical manifestation of neuroanatomical dysfunction, neuropsychological assessment is unique in its ability to guide treatment and assist with decisions regarding functional needs. Neuropsychologists are capable of utilizing objective test data to thoroughly assess patients’ abilities to make legal, financial, and healthcare decisions; their need for supervision; their ability to live independently and to return to work ( ). Neurocognitive assessments may also be used to guide treatment plans by identifying cognitive deficits for specific rehabilitation strategies. For example, patients with behavioral disinhibition and poor emotional regulation due to lesions in the orbitofrontal cortex can be targeted for behavioral modification strategies and training in self-monitoring ( ). Neuropsychological assessments are also useful for evaluating patients’ candidacy for certain surgical procedures. Neurosurgeons considering a temporal lobectomy for refractory epilepsy often call on neuropsychologists to conduct Wada testing to localize language, memory, or motor functioning in order to minimize postoperative cognitive losses. Neuropsychological assessment is also used prior to the placement of a deep brain stimulator to help predict post-surgical outcomes.

Lastly, neurocognitive testing is useful for monitoring treatment effectiveness and patients’ recovery from acquired brain injuries. For instance, neuropsychologists use their expertise to determine whether a coma patient has progressed into a vegetative or minimally conscious state ( ). Accurate monitoring is vital, given the differences in clinical outcomes for each level of consciousness and the danger of making erroneous decisions regarding the withdrawal of treatment. Treatment effectiveness can also be monitored using repeat assessments to determine whether medical, pharmacological, and rehabilitation interventions are having their desired cognitive effects. Monitoring treatment effectiveness leads to more efficient utilization of resources by updating treatment plans as necessary.

Neuropsychological Evaluation

Depending on the referral question and clinical setting, neuropsychological assessments can range from quick bedside assessments to extended evaluations that include formal standardized testing and a comprehensive clinical interview. A complete neuropsychological interview covers the onset and course of the patient’s cognitive and mood problems, current functional capacity, developmental background, medical, psychiatric, and family history, academic performance, vocational achievements, and social background. Information obtained from collateral sources such as caregivers or spouses about the patient’s medical and psychosocial history can also be critical because many patients lack insight into their deficits. Besides gathering patient-reported information, the goals of the neuropsychological interview are to develop hypotheses about the patient’s cognitive status and to establish rapport that will elicit their best performance on testing. Behavioral observations made during the interview and testing are also an important source of information that can influence test selection and interpretation. After a clinical interview is completed, the following cognitive domains are assessed: sensory, motor, intellectual functioning, processing speed, attention, language, visuoperception, constructional praxis, memory, executive functioning (behavioral, cognitive, and motivational aspects), functional capacity, and emotional/personality functioning.

Test Administration

Early approaches to neuropsychological evaluation tended to use a fixed battery approach requiring that the same tests are administered to every patient in a standardized manner. One example of a fixed battery is the Halstead–Reitan battery ( Box 44.1 ), for which comprehensive norms have been published by Heaton and colleagues ( ). While this approach had the benefit of providing comprehensive assessment of cognitive functioning, the length of the battery (up to 8 hours), which was not tolerated by all patients, was not always necessary to address the referral question, and is often incompatible with the limited reimbursement schedules in managed care. For these reasons, the flexible battery (or hypothesis-driven battery) is more commonly used today.

BOX 44.1
Heaton Adaptation of Halstead–Reitan Neuropsychological Test Battery
Adapted from Heaton, R.K., Grant, I., Matthews, C.G., 1991. Comprehensive Norms for Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Psychological Assessment Resources, Odessa, FL.

  • Tactual performance test

  • Finger oscillation test

  • Category test

  • Seashore rhythm test

  • Speech sounds perception test

  • Aphasia screening test

  • Sensory-perceptual examination

  • Grip strength test

  • Tactile form recognition test

  • Wechsler adult intelligence scale—revised

  • Wechsler memory scale—revised

The flexible battery approach allows neuropsychologists to develop a test battery based on the referral question, patient’s history, and clinical interview. In the flexible battery approach, a brief set of basic tests is initially administered, and additional tests of more specific abilities are used to conduct in-depth follow-up assessments based on each patient’s needs. For an example of this, see the Iowa-Benton method as illustrated in Fig. 44.1 ( ). Considerations when selecting tests include age, primary language, level of education, ethnicity/cultural factors, reading level, expected level of global cognitive impairment (to avoid ceiling or floor effects in testing), and physical disabilities ( ). Although this approach is more tailored to the individual needs of the patient (and is therefore briefer), it can be less comprehensive than the fixed-battery approach. Most neuropsychologists’ approaches fall somewhere between the use of a set battery and a completely individualized examination.

Fig. 44.1, Example of a Flexible Battery Approach.

Test Interpretation

The interpretation of cognitive test results is central to the role of the neuropsychologist and differentiates neuropsychology from all other disciplines. Accurate interpretation of neuropsychological test results depends on a comprehensive understanding of the neuroanatomical correlates of cognition, neurological disease processes, and psychometric testing principles. One cannot simply administer a test, look at the score, and declare that the score indicates intact/impaired cognitive functioning. Test interpretation requires an understanding of test validity and reliability, sensitivity and specificity, likelihood ratios, and score distributions to avoid over- or underdiagnosing cognitive deficits. Substantial intraindividual differences exist in cognitive abilities, and a small number of poor test performances within a larger battery of tests is common among the general population. Cognitive test performances are also impacted by extra-neurological factors such as the number of tests administered, where cut scores are placed, the probability of certain test scores occurring, and the demographic characteristics of the patient ( ). Proper test interpretation requires that all of these variables are considered and that conclusions are based on recognizable patterns of test results rather than the interpretation of test scores in isolation.

Neuropsychological test interpretation is also dependent on an understanding of the scientific and theoretical concepts that underlie cognitive tests. No cognitive test measures a single isolated aspect of cognitive functioning. Most neuropsychological tests engage multiple cognitive abilities simultaneously. To illustrate, verbal memory tests (e.g., word list memory tasks) assess memory functioning, but they are also dependent on the patient’s attention, processing speed, and executive functioning. Therefore, an impaired score on a verbal memory task does not necessarily indicate a primary memory impairment. It is the neuropsychologist’s task to determine which cognitive deficits are actually causing impaired test performances by analyzing the patient’s overall pattern of results across the test battery and by comparing the neuropsychological profile to known patterns of disease. If a score on a verbal memory test does reflect a primary memory deficit, then the neuropsychologist determines whether the impairment is due to a deficit in encoding, storage, or retrieval, since the type of memory impairment may be indicative of different disease processes or lesion locations. Neuropsychologists use a similar method of analysis when assessing performances in other cognitive domains.

Test interpretation also requires the integration of neuropsychological test scores with findings from the clinical interview, the patient’s history, the neurological examination, neurophysiology and neuroimaging data, and relevant literature. Raw test scores must be compared to an appropriate reference standard. Several reference standards are used in interpreting neuropsychological test scores, including the use of normative data, cut scores, and comparisons with an individual’s own prior testing results.

Inferences about individual patients’ neuropsychological test scores are often derived by comparing test scores to normative data that are typically collected by test developers as a standardization sample. Normative data are useful for accounting for variables that are likely to influence test performance (e.g., demographic factors) so that accurate and appropriate conclusions are drawn. Confounding variables are accounted for by stratifying test scores according to sex, age, and level of education. An individual’s raw score is compared with the distribution of scores from his or her peer group to determine where it falls within the range of expected performances. Fig. 44.2 and Table 44.2 show a normal distribution and interpretive guidelines for use in neuropsychological interpretation. The usefulness of normative data depends strongly on the size and representativeness of the standardization sample. Clinical interpretation can also be greatly affected by the goodness-of-fit between the individual patient and the standardization sample. Furthermore, it is important to use the most recent norms available, because cohort effects may lead to differences between current patients and those from whom data were collected years ago. When appropriate norms are not available, there is a danger of over- or underdiagnosis of cognitive impairment.

Fig. 44.2, The Normal Curve and Its Relationship to Derived Scores.

TABLE 44.2
Descriptive Terms Associated With Performance Within Various Ranges of the Normal Distribution
Qualitative Terms Standard Deviation Score (i.e. Z-Score) T-Score Percentile Rank
Severely impaired <−2.20 <29 <2
Moderately impaired −2.20 to −1.60 29–34 2–5
Mildly impaired −1.59 to −1.33 35–37 6–9
Below average −1.32 to −0.68 38–42 10–24
Average −0.67 to +0.67 43–57 25–75
Above average +0.68 to +1.59 58–66 76–94
Superior +1.60 to +2.20 67–72 95–98
Very superior >+2.20 >72 >98
Note: The patient’s educational history and premorbid level of functioning should be taken into consideration in applying any qualitative label.

Another approach to test interpretation is the use of cut scores. Tests that rely on cut scores often measure performances with low base rates or deficits very few healthy people demonstrate. Some tests are straightforward in their capability to measure abilities that are largely intact in normal subjects but impaired in disordered patients. For example, most people are able to bisect a line without difficulty, but patients with left-sided visuospatial neglect typically identify the midpoint of the line to be to the right of center. Cut scores are useful with brief tests of cognitive screening, such as the Mini-Mental State Examination (MMSE). It is critical to remain current with normative standards, however, as even these very brief screening tests vary greatly with persons varying in education and ethnicity. See Table 44.3 for MMSE cutoff scores for detection of Alzheimer disease varying by ethnicity ( ). One recent study of over 10,450 Medicare recipients suggested that claims data and cognitive performances were poorly matched, with less than half being identified by both measures, suggesting that healthcare providers underestimated dementia diagnoses in Black and Hispanic populations, compared with Whites ( ).

TABLE 44.3
Mini-Mental State Examination Cutoff Scores for Detection of Alzheimer Disease Varying by Ethnicity
Cohort Age Prevalence of MCI Confidence Interval
60–64 6.7% 3.4–12.7
65–69 8.4% 5.2–13.4
70–74 10.1% 7.5–13.5
80–84 25.2% 16.5–36.5
MCI, Mild cognitive impairment.

The comparison of current performance with past test scores is another important component of test interpretation, especially if cognitive decline is suspected. Rarely, however, do individuals have previous test data available for these comparisons. When no previous test scores are available, evidence of the patient’s premorbid intellectual functioning is estimated. Several techniques are available for estimating premorbid intellect, including regression equations that utilize demographic variables as predictors of IQ (e.g., the Barona formula; ), word reading tests that are correlated with IQ (e.g., the North American Adult Reading Test; or the Word Reading Test from the Wide Range Achievement Test; ), and “hold” subtests from intelligence measures that are frequently used as proxies for premorbid functioning (e.g., see , for review). Most contemporary neuropsychologists use a combination of these strategies, either formally (e.g., Oklahoma Premorbid Intelligence Estimate-3, ; Test of Premorbid Functioning, ) or informally.

Ultimately, feedback about the results of the neuropsychological evaluation, along with diagnostic impressions and treatment recommendations, is communicated to the referring physician and the patient. Some form of written report is typical in neuropsychological evaluations, and these tend to vary in length and level of detail (e.g., <1–15 pages). A common structure for a neuropsychological report includes sections summarizing the patient interview, collateral interview, medications, medical history, social background, behavioral observations, neuropsychological battery, neuropsychological test results and interpretation, final diagnostic impressions, and treatment recommendations.

Brief Mental Status Examination

Before referring a patient for a neuropsychological evaluation, the neurologist typically has either clinical or historical evidence of cognitive concerns. This might come from patient self-report or collateral report, an informal mental status examination, or a brief objective screening measure of mental status. Although many mental status examinations are conducted in a nonstandard manner, neurologists are encouraged to use formal cognitive screening measures to develop a standardized method of mental status examination so comparisons across time and patients can be reliably made. One purpose of cognitive screening measures is to determine the need for a more extended evaluation of neuropsychological functioning. Given the limited scope of cognitive screening measures and the psychometric considerations noted earlier, it is not recommended that cognitive screening measures be used as a final summation of a patient’s cognitive status. Scores from cognitive screeners must be considered in conjunction with clinical observation and judgment to determine whether a referral for neuropsychological evaluation is necessary, since many patients may pass a cognitive screen but still have suspected deficits that warrant more sensitive neuropsychological testing. The Patient Protection and Affordable Care Act of 2010 suggests conducting an annual wellness visit for all Medicare patients, including a cognitive assessment. The Alzheimer’s Association describes many suggested screening questionnaires on their website and provides validated assessment tools recommended to primary care physicians ( https:// www.alz.org ).A few suggested objective screening measures of cognitive functioning that may be useful for neurologists to administer are briefly described in the following.

Mini–Mental State Examination

One of the most widely used mental status examinations is the MMSE ( ), a 30-point standardized screening tool for assessing orientation, attention, short-term recall, naming, repetition, simple verbal and written commands, writing, and construction ( Fig. 44.3 ). The MMSE has been used in a variety of settings (e.g., community, institutions, general hospitals, specialty clinics), with many different neurological and psychiatric conditions (e.g., dementia, stroke, depression), across age ranges, and with different cultural and ethnic subgroups. Demographic variables such as age and education have been shown to systematically influence MMSE scores, so normative data or cut scores should account for these variables. One example of appropriate norms comes from the Epidemiologic Catchment Area study ( ); these are presented in Table 44.4 . Whereas many intact individuals achieve total scores near 30, a cut score of 23 on the MMSE has been shown to have adequate sensitivity and specificity (86% and 91%, respectively) for detecting dementia in community samples ( ). However, when working with highly educated patients (i.e., ≥16 years of formal education) a cut score of 27 is recommended ( ).

Fig. 44.3, Mini–Mental State Examination.

TABLE 44.4
Mini-Mental State Examination Score by Age and Educational Level, Number of Participants, Mean, Standard Deviation, and Selected Percentiles
  • Data from the Epidemiologic Catchment Area household surveys in New Haven, CT; Baltimore, MD; St. Louis, MO; Durham, NC; and Los Angeles, CA, between 1980 and 1984. The data are weighted based on the 1980 US population census by age, sex, and race.

  • Adapted from Crum, R.M., Anthony, J.C., Bassett, S.S., et al., 1993. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269, 2386–2391.

Age (Years) 18–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 ≥85 Total
Educational Level
0–4 years 17 23 41 33 36 28 34 49 88 126 139 112 105 61 892
Mean 22 25 25 23 23 23 23 22 23 22 22 21 20 19 22
SD 2.9 2.0 2.4 2.5 2.6 3.7 2.6 2.7 1.9 1.9 1.7 2.0 2.2 2.9 2.3
5–8 years 94 83 74 101 100 121 154 208 310 633 533 437 241 134 3223
Mean 27 27 26 26 27 26 27 26 26 26 26 25 25 23 26
SD 2.7 2.5 1.8 2.8 1.8 2.5 2.4 2.9 2.3 1.7 1.8 2.1 1.9 3.3 22
9–12 years or high school diploma 1326 958 822 668 489 423 462 525 626 814 550 315 163 99 8240
Mean 29 29 29 28 28 28 28 28 28 28 27 27 25 26 28
SD 2.2 1.3 1.3 1.8 1.9 2.4 2.2 2.2 1.7 1.4 1.6 1.5 2.3 2.0 1.9
College experience 783 1012 989 641 354+ 259 220 231 270 358 255 181 96 52 5701
Mean 29 29 29 29 29 29 29 29 29 29 28 28 27 27 29
SD 1.3 0.9 1.0 1.0 1.7 1.6 1.9 1.5 1.3 1.0 1.6 1.6 0.9 1.3 1.3
Total 2220 2076 1926 1443 979 831 870 1013 1294 1931 1477 1045 605 346 18,056
Mean 29 29 29 29 28 28 28 28 28 27 27 26 25 24 28
SD 2.0 1.3 1.3 1.8 2.0 2.5 2.4 2.5 2.0 1.6 1.8 2.1 2.2 2.9 2.0

Despite its widespread use, the MMSE has some drawbacks. First, it only assesses a limited number of cognitive functions. Second, a potential threat to the test’s internal validity is the nonstandard administration of some of the items. Examples of these frequent adaptations of the MMSE include the use of nonorthogonal (i.e., semantically related) word stimuli for registration and recall, nonstandard scoring of serial 7’s, and nonstandard inclusion of spelling world backward. Another drawback of the MMSE is that it has “ceiling effects” that can miss cognitive impairments in high-functioning individuals. The MMSE also has difficulty differentiating individuals with mild cognitive impairment (MCI) from controls and those with dementia ( ). Finally, because this test relies on a single total score, partial administration of the measure (e.g., due to sensory impairments of the patient) provides no information about cognitive status. This same limitation is true for the Montreal Cognitive Assessment (MoCA). The MMSE is now copyrighted and is available for purchase.

Modified Mini-Mental State Examination

Some of the criticisms of the MMSE led to the development of the Modified Mini-Mental State Examination (3MS) ( ), a 14-item extension of the MMSE that assesses orientation (self, time, place), attention (simple and complex), memory (recall and recognition), language (naming, verbal fluency, repetition, following commands, writing), construction, and executive functioning (similarities). It remains relatively brief to administer (10 minutes), and age- and education-corrected normative data are available ( ). Regression-based prediction formulas for the 3MS allow for more accurate assessments of change across time ( ). The broader scoring range (0–100) has been shown to be more sensitive than that of the MMSE in identifying dementia ( ) and other cognitive disorders ( ) in large community samples. A cut score for cognitive impairment is typically 77 ( ), and a change of 5 points over the course of 5–10 years indicates the presence of clinically meaningful decline ( ).

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here